ComplianceOnline

How to Transfer Non-Compendial and Developed QC Procedures - ICH and USP Guidelines

Instructor: Barbara Berglund
Product ID: 701845
  • Duration: 90 Min

recorded version

$249.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: May-2017

Training CD / USB Drive

$349.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This webinar will explain ICH and USP guidelines for validation and how to apply ICH guidelines for method transfer and how to establish boundaries.

Why Should You Attend:

Once a product goes commercial, measuring the quality, safety, and efficacy attributes of the drug substance and the drug product is crucial. There are well-established ICH guidelines for the validation requirements of typical analytical procedures. In contrast, the requirements for a technical transfer of an analytical procedure from one site to another or within a site to a separate facility are often debated.

It is critical that a robust transfer program be put into place in order to head off issues. Unearthing issues at the drug development stage, rather than during routine manufacture, will improve the overall success of the project. Attend this webinar to understand the ICH and USP guidance for validation, and how to apply ICH guidelines for method transfer and how to establish boundaries.

Areas Covered in the Webinar:

  • ICH guidelines for validation.
  • USP guidelines for validation and verification.
  • Applications of the ICH guidelines for method transfer.
  • Debated topics and approaches.
  • Complex procedures.
  • Establishing boundaries.

Who Will Benefit:

This webinar will provide valuable assistance to all personnel in:

  • QC functions in general
  • QC technical transfer groups
  • QC validation groups
  • Commercial testing facilities
  • Product development
  • Commercial project support

Instructor Profile:
Barbara Berglund

Barbara Berglund
COO, CMC Turnkey Solutions

Barbara Berglund, has been working in the pharmaceutical and medical device industry, specifically with sterile parenteral dugs, for over 15 years. Her experience includes her current role as a QC Manager as well as roles in the laboratory, project management, and clinical trial manufacturing. The QC group she currently manages is directly responsible for testing of products used in support of the medical device industry; she previously managed a QC team responsible for procedure transfer and validation in support of parenteral pharmaceutical products. She has an undergraduate degree in Chemistry and post graduate degrees in Chemistry and Pharmacological and Physiological Science. She received her PMP certification in 2007 and her Green Belt certification in 2008.

Topic Background:

Analytical procedures are typically developed early in the clinical trial phases of drug development. The procedures may measure content, characters, or known impurities at this phase. During the movement of the trials toward commercial product status, formulations change, concentrations change, and presentations change. For many reasons, including the cost of method development, the procedures are not updated or changed as the phase of the product goes forward. Also, the knowledge management piece is not always accessible.

By the time a procedure is transferred to a receiving lab for routine testing of a commercial product, it is not uncommon for the original procedure to be validated for forward use. In some cases, this is perfectly acceptable. In other cases, there have been enough changes to the formulation, concentration, or presentation that the original procedure has lost some ruggedness. In addition, there may be attributes of the formulation which have become masked during the development of the drug. It is critical that a robust transfer program be put into place in order to head off issues. Unearthing issues at this stage, rather than during routine manufacture, will improve the overall success of the project.

Follow us :
Upcoming In-person Seminars by EX-FDA OFFICIALS
Recordkeeping and Documentation in a GLP Laboratory

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading